Rigrodsky Law, P.A. Is Investigating BioMarin Pharmaceutical Inc.

[ad_1]  Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) on behalf of stockholders. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-biomarin-pharmaceutical-inc. To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email [email protected]. Rigrodsky Law, […]

Dictionary of miracles!The appeal judge rejected the $4.5 billion Purdue Pharmaceuticals opioid settlement agreement to save Sackler from civil litigation

[ad_1] Every once in a while, the system will work. We have embedded a ruling by Judge Colleen McMahon for the Southern District of New York that favors a group of plaintiffs, including Connecticut and seven other states, against Purdue’s settlement agreement because it protects Sackler Family, the latter has divested most of Purdue Pharmaceuticals’ […]

Psychedelic landscape: pharmaceutical, technology, Decrim, others

[ad_1] We have been writing articles about psychedelics on this blog for three years.I believe first time I wrote that the Food and Drug Administration (FDA) approved Comp360 Pathway’s COMP360 drug trial, which is a psilocybin preparation that was eventually Obtained a patentSince then, many things have happened in this space, and we have seen […]

New wave of pharmaceutical companies competing for Covid vaccine market share

[ad_1] This article is the live version of our coronavirus business update newsletter. Please share this article with friends and colleagues who may find it valuable, and let them know that even if they are not a subscriber of the Financial Times, they can read the newsletter for free-and all FT-for 30 days.Welcome and Please […]

Has the influence of the major pharmaceutical industry on US trade policy faded?

[ad_1] This article is the live version of the “Trade Secrets” press release.registered Here Get a complete newsletter, sent directly to your inbox every Monday to Thursday Hello, Washington, I am writing your new “DC Trade Secrets” notes that you have highlighted. Although by the time you read this article, I will be in Georgia, […]